US · Healthcare · Drug Manufacturers - Specialty & Generic
EPS came in at 0.11 against a street estimate of 0.03 — a beat of 266.7%.
Analysts rate Trulieve Cannabis Corp. a strong buy (7 buy, 0 hold, 0 sell out of 7) with an average price target of $18.18.
| Fund | Stake |
|---|---|
| AdvisorShares Investments, LLC | 5.53% |
| Oakmont Corp | 0.78% |
| HighTower Advisors, LLC | 0.08% |
| Sierra Summit Advisors LLC | 0.08% |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 0.06% |
| Bluechip Wealth Advisors LLC | 0.06% |
| JW Asset Management, LLC | 0.04% |
| Harbor Advisors LLC | 0.02% |
| Document | Date |
|---|---|
| Quarterly report · Q3 2026 HEADLINE NUMBERS • Q3 2026 revenue was $230,215 thousand, down from $288,187 thousand in Q3 2025. • Q3 gross profit was $148,020 thousand, compared | 2026-11-05 |
| Results announced · Q4 2026 HEADLINE NUMBERS • Q3 2026 revenue was $230 million, down 20% from $288 million in Q3 2025 and down 15% from $271 million in Q2 2026. • Gross profit | 2026-11-05 |
| Material agreement · Q3 2026 TRULIEVE CANNABIS CORP. – FORM 8-K SUMMARY HEADLINE NUMBERS • Company: Trulieve Cannabis Corp., traded as TRLV on NYSE • Headquarters: 3494 Martin H | 2026-08-11 |
| Quarterly report · Q2 2026 TRULIEVE CANNABIS CORP. — Q2 2026 SUMMARY HEADLINE NUMBERS • Revenue Q2 2026: $270.952 million (down from $302.086 million Q2 2025) • Revenue H1 202 | 2026-08-07 |
| Acquisition completed · Q3 2026 TRULIEVE CANNABIS CORP. - FORM 8-K SUMMARY HEADLINE NUMBERS • Filing Date: August 7, 2026 • Reporting Period: Three and six months ended June 30, 20 | 2026-08-07 |
| Shareholder vote results · Q3 2026 TRULIEVE CANNABIS CORP. - FORM 8-K SUMMARY HEADLINE NUMBERS • Special shareholder meeting held August 5, 2026 • Delaware Domestication proposal: 71, | 2026-08-05 |
| Board / officer change · Q2 2026 TRULIEVE CANNABIS CORP. - FORM 8-K SUMMARY HEADLINE NUMBERS • Report Date: June 30, 2026 • Company: Trulieve Cannabis Corp. (Ticker: TRLV, NYSE) • H | 2026-07-02 |
| Proxy statement · Q2 2026 TRULIEVE CANNABIS CORP. — PROXY STATEMENT SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Delaware Domestication — Special resolution to appro | 2026-06-25 |
Readable in the app.
| Announcement | Date |
|---|---|
| Board authorizes $50M share repurchase program over 12 months Trulieve Cannabis Corp. announced a share repurchase program on June 9, 2026, authorizing the company to buy back up to $50 million worth of its own stock, or a maximum of 8,495,038 shares ( | 2026-06-09 |
| $100M Senior Secured Notes issued for capital expenditures and corporate purposes Trulieve Cannabis Corp. announced on December 8, 2025, that it secured $100 million in commitments for senior secured notes due in 2030. Key terms: The notes carry a 10.5% annual interest ra | 2025-12-09 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Trulieve Cannabis Corp. — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.